165 related articles for article (PubMed ID: 20932226)
1. Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response.
Miroux C; Vausselin T; Delhem N
Expert Opin Biol Ther; 2010 Nov; 10(11):1563-72. PubMed ID: 20932226
[TBL] [Abstract][Full Text] [Related]
2. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
[TBL] [Abstract][Full Text] [Related]
3. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
4. [Regulatory T-cells and hepatocellular carcinoma: implication of the regulatory T lymphocytes in the control of the immune response].
Delhem N; Carpentier A; Moralès O; Miroux C; Groux H; Auriault C; Pancré V
Bull Cancer; 2008 Dec; 95(12):1219-25. PubMed ID: 19091657
[TBL] [Abstract][Full Text] [Related]
5. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
6. Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis.
Itose I; Kanto T; Kakita N; Takebe S; Inoue M; Higashitani K; Miyazaki M; Miyatake H; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
J Viral Hepat; 2009 Dec; 16(12):844-52. PubMed ID: 19486278
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma.
Attallah AM; Tabll AA; El-Sadany M; Ibrahim TA; El-Dosoky I
Clin Exp Med; 2003 Nov; 3(3):181-5. PubMed ID: 14648234
[TBL] [Abstract][Full Text] [Related]
8. Immune responses in hepatocellular carcinoma.
Korangy F; Höchst B; Manns MP; Greten TF
Dig Dis; 2010; 28(1):150-4. PubMed ID: 20460904
[TBL] [Abstract][Full Text] [Related]
9. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus infection and liver transplantation.
Kennedy M; Alexopoulos SP
Curr Opin Organ Transplant; 2010 Jun; 15(3):310-5. PubMed ID: 20445447
[TBL] [Abstract][Full Text] [Related]
11. Relationship of peripheral blood CD4-positive T cells to carcinogenesis in patients with HCV-related chronic hepatitis and liver cirrhosis.
Matsui T; Nagai H; Sumino Y; Miki K
Cancer Chemother Pharmacol; 2008 Aug; 62(3):401-6. PubMed ID: 17932673
[TBL] [Abstract][Full Text] [Related]
12. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
Leone N; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
[TBL] [Abstract][Full Text] [Related]
13. Expression of membrane cofactor protein (MCP, CD46) in human liver diseases.
Kinugasa N; Higashi T; Nouso K; Nakatsukasa H; Kobayashi Y; Ishizaki M; Toshikuni N; Yoshida K; Uematsu S; Tsuji T
Br J Cancer; 1999 Aug; 80(11):1820-5. PubMed ID: 10468303
[TBL] [Abstract][Full Text] [Related]
14. [Monitoring patients with chronic hepatitis during and after therapy].
Colić-Cvrlje V; Mise S
Acta Med Croatica; 2009 Dec; 63(5):377-83. PubMed ID: 20198895
[TBL] [Abstract][Full Text] [Related]
15. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.
Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A
Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
17. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
Schott E; Bergk A; Berg T
Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
[TBL] [Abstract][Full Text] [Related]
18. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.
Ormandy LA; Hillemann T; Wedemeyer H; Manns MP; Greten TF; Korangy F
Cancer Res; 2005 Mar; 65(6):2457-64. PubMed ID: 15781662
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells play divergent roles in shaping the outcome of hepatitis C virus recurrence following liver transplantation.
Golden-Mason L
Liver Transpl; 2009 Apr; 15(4):357-9. PubMed ID: 19326413
[No Abstract] [Full Text] [Related]
20. Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation.
Unitt E; Marshall A; Gelson W; Rushbrook SM; Davies S; Vowler SL; Morris LS; Coleman N; Alexander GJ
J Hepatol; 2006 Aug; 45(2):246-53. PubMed ID: 16580084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
